SIFI SpA Strategic SWOT Analysis Review [Updated: 15022017] Prices from USD $125

17:22 EST 6 Mar 2017 | BioPortfolio Reports

SIFI SpA Strategic SWOT Analysis Review provides a comprehensive insight into the company's history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company's key employees, key competitors and major products and services.

This uptotheminute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.


Business description A detailed description of the company's operations and business divisions.
Corporate strategy GlobalData's summarization of the company's business strategy.
SWOT analysis A detailed analysis of the company's strengths, weakness, opportunities and threats.
Company history Progression of key events associated with the company.
Major products and services A list of major products, services and brands of the company.
Key competitors A list of key competitors to the company.
Key employees A list of the key executives of the company.
Executive biographies A brief summary of the executives' employment history.
Key operational heads A list of personnel heading key departments/functions.
Important locations and subsidiaries A list of key locations and subsidiaries of the company, including contact details.
Key manufacturing facilities A list of key manufacturing facilities of the company.


SIFI SpA SIFI is an integrated ophthalmic company that focuses on eye care products. It develops, manufactures and markets pharmaceutical products, diagnostic instruments and surgical equipment for the prevention and treatment of the most common ocular pathologies. SIFI develops its products in various dosage forms including ointments, eye drops, pills and capsules. Its products find application in the areas of corneal abrasions, cataract, glaucoma, infections, inflammation, dry eye, and retinopathies. SIFI has subsidiaries in Mexico and Romania; and a network of distributors in Russia, Spain, the UK, Mexico, Romania and Turkey. It conducts research in the areas of diagnostics and surgery. SIFI is headquartered in Catania, Sicilia, Italy.

SIFI SpA Key Recent Developments

Jan 14, 2016: SIFI announces the expansion of its product portfolio with the return on the Italian market of Colbiocin eye drops

Reasons to Buy

Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
Identify potential customers and suppliers with this report's analysis of the company's business structure, operations, major products and services and business strategy.
Understand and respond to your competitors' business structure and strategies with GlobalData's detailed SWOT analysis. In this, the company's core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
Examine potential investment and acquisition targets with this report's detailed insight into the company's strategic, business and operational performance.

Note: Some sections may be missing if data is unavailable for the company.

Original Article: SIFI SpA Strategic SWOT Analysis Review [Updated: 15022017] Prices from USD $125


More From BioPortfolio on "SIFI SpA Strategic SWOT Analysis Review [Updated: 15022017] Prices from USD $125"

Quick Search


Relevant Topic

Ophthalmology is the branch of medicine that is devoted to the study and treatment of eye diseases. As well as mild visual defects correctable by lenses, ophthalmology is concerned with glaucoma, uveitis and other serious conditions affecting the eye, ...